Monthly Archives: July 2016

Featured Stories

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Levaquin Complaint can be Amended to Include FDA Warning, Court Says

Levaquin Complaint can be Amended to Include FDA Warning

In May 2016, the U.S. Food and Drug Administration (FDA) warned about the risks of fluoroquinolone antibiotics, which include Levaquin, Avelox and Cipro. The agency said that, given the risk of potentially permanent side effects, these medications should only be … Continue reading

Posted in Cipro, Levaquin, Pharmaceuticals | Tagged , , , , |

Zithromax Linked to Rare but Extremely Serious Skin Side Effect

Zithromax Linked to Rare but Very Serious Skin Side Effect

Zithromax, a widely prescribed antibiotic, has been linked to a number of severe side effects, including the serious allergic skin reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Stevens-Johnson is “a rare, serious disorder” of the skin and mucous … Continue reading

Posted in Pharmaceuticals, Zithromax | Tagged , , , , |

FDA Updates Abilify Label to Include Compulsive Behaviors

FDA Updates Abilify Label to Include Compulsive Behaviors

The U.S. Food and Drug Administration (FDA) has updated the warning label on Abilify, Abilify Maintena, Aristada and generic aripiprazole to include information about compulsive behavior. According to the safety announcement, there have been reports of uncontrollable urges to gamble, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

FDA Revises Warning Label on Fluoroquinolone Antibiotics

FDA Revises Warning Label on Fluoroquinolone Antibiotics

The U.S. Food and Drug Administration (FDA) has approved labeling changes on fluoroquinolone antibiotics, which include levofloxacin (Levaquin), ciprofloxacin (Cipro), ciprofloxacin extended-release tablets, moxifloxacin (Avelox), ofloxacin and gemifloxacin (Factive). In a news release issued Tuesday, the agency said the Boxed … Continue reading

Posted in Cipro, Levaquin, Pharmaceuticals | Tagged , , , , , , , , , , , |

Zofran Birth Defect Lawsuit Update: “Sequence Discovery” Issue

Zofran Birth Defect Case Update: “Sequence Discovery” Issue

Plaintiffs in more than 200 birth defect lawsuits have raised concerns over the pharmaceutical company GlaxoSmithKline’s (GSK) new proposal for Sequenced Discovery. Parents say the company neglected to warn patients and health experts of its anti-nausea drug Zofran’s alleged potential … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Invega Users Troubled by Range of Side Effects

Patients taking the psychiatric medication Invega, approved for the treatment of schizophrenia, face a range of side effects, some of which can persist even after the patient stops taking the drug. Invega (paliperidone) is made by Janssen Pharmaceuticals. Invega is … Continue reading

Posted in Legal News |

Dilantin Linked to Stevens-Johnson Syndrome, a Dangerous Skin Condition

Dilantin Linked to Stevens-Johnson Syndrome

Dilantin, the anti-epileptic drug that has been in use for decades is one of many drugs associated with the related skin conditions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Though these conditions are rare, when they do occur they … Continue reading

Posted in Acetaminophen / Tylenol, Dilantin, Health Concerns, Lamictal, Pharmaceuticals, Zithromax | Tagged , , , , |

Levaquin Plaintiffs Allowed to Include Updated FDA Safety Warnings in Legal Complaints

Levaquin Plaintiffs Able to Use Updated FDA Safety Warnings

Hundreds of product liability lawsuits involving the fluoroquinolone antibiotics Levaquin, Cipro and Avelox are moving toward trial in a multidistrict litigation (MDL) in the U.S. District Court, District of Minnesota. In June 2016, the court granted a motion from the … Continue reading

Posted in Cipro, Levaquin, Pharmaceuticals | Tagged , , , , , , , |

Tainted Medical Scopes Allegedly Cause Superbug Infections

Tainted Medical Scopes Allegedly Cause Superbug Infections

The Olympus Corporation, based in Japan, was allegedly aware of superbug outbreaks in three countries as early as 2013 and did not alert American hospitals about possibly deadly infections from contaminated medical scopes known as duodenoscopes. After two-dozen infections were … Continue reading

Posted in Defective Medical Devices, Duodenoscope, Health Concerns | Tagged , , , , , , , |

Xarelto Lawsuits Have Added Credibility Based on Scholarly Studies

Xarelto Cases Added Credibility Based on Scholarly Studies

The makers of Xarelto, an anticoagulant that was credited as a breakthrough in blood clot prevention, is battling numerous lawsuits. An alleged connection between an elevated risk for serious hemorrhages and Xarelto are now being lent possible increased credibility through … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.